Breast Neoplasms: all 12,828 studies

Page 61 of 129. Open to participants first (2,932), then studies with results posted, then the rest; newest registration first within each.

• Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant ChemotherapyStatus unknownNCT05512468Not applicable
• Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast CancerStatus unknownNCT05512416Phase 2
• Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening ProgramsWithdrawnNCT05512260Not applicable
• Efficacy of Acupuncture Treatment for Breast Cancer-associated InsomniaActive, not recruitingNCT05510700Not applicable
• Incidence and Prognostic Significance of HER-2 Status Discordance Between Primary Breast Cancer and Paired Recurrent/Metastatic LesionsCompletedNCT05510037
• A Study of LY3484356 in Chinese Participants With Advanced Breast CancerActive, not recruitingNCT05509790Phase 1
• The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support PersonActive, not recruitingNCT05509751Not applicable
• Clinical Outcomes and Patient Satisfaction With Use of the Amma SystemActive, not recruitingNCT05508984
• Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast CancerActive, not recruitingNCT05508906Phase 1
• The Anti-tumor Effect of Metformin And Atorvastatin in Breast CancerStatus unknownNCT05507398Phase 4
• Life Style Modification for Breast Canccer Survivors Using Mobile App-based Human Coaching ProgramCompletedNCT05506189
• Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBCCompletedNCT05505175
• Protection of Cardiovascular Function With Crocin in BrEast Cancer Patients Undergoing Radiotherapy and ChemotherapyStatus unknownNCT05504148Not applicable
• Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast CancerSuspendedNCT05503108Phase 3
• Multidisciplinary Approach to FatigueTerminatedNCT05502224Not applicable
• Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)Active, not recruitingNCT05501886Phase 3
• ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast CancerCompletedNCT05501769Phase 1
• CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian PopulationStatus unknownNCT05501158Not applicable
• Breast Cancer With Intraoperative Radiotherapy Followed by Hypofractionated External Beam RadiotherapyStatus unknownNCT05498311Phase 2
• Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast CancerStatus unknownNCT05494281Not applicable
• To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast CancerStatus unknownNCT05491694Phase 2
• A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast CancerTerminatedNCT05489679Phase 1
• mHealth Usage Among Nigeria Women Diagnosed With Breast Cancer Receiving ChemotherapyCompletedNCT05489354Not applicable
• A Study of Tumor Imaging With Multispectral Optoacoustic TomographyActive, not recruitingNCT05488483
• RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/TruebeamStatus unknownNCT05486936
• Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast CancerActive, not recruitingNCT05486182Phase 4
• The Effect of Guided Imagery Based on the Health Promotion Model on the Quality of Life in Breast Cancer PatientsCompletedNCT05484180Not applicable
• A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast CancerStatus unknownNCT05483439Phase 2
• A Study to Describe Treatment Patterns of Advanced Breast Cancer in Poland in the Real-world Data SettingCompletedNCT05478590
• A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast CancerWithdrawnNCT05474690Phase 3
• MammaPrint Value for Pre-menopausal Breast Cancer PatientsActive, not recruitingNCT05474391
• Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)CompletedNCT05472532Not applicable
• Design of Chatbot Persona for Breast Cancer Screening Outreach Among Black WomenCompletedNCT05472064
• A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male VolunteersCompletedNCT05471648Phase 1
• Dalpiciclib Plus Letrozole and CapecitabineStatus unknownNCT05469750Phase 2
• Inflammatory Blood Markers in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyStatus unknownNCT05468710
• Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast CancerActive, not recruitingNCT05466786
• PET/MR Radiomics for Breast Cancer DiagnosisStatus unknownNCT05466760
• Preoperative Irradiation for Stage I Breast CancerActive, not recruitingNCT05464667Not applicable
• Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast CancerActive, not recruitingNCT05463601Phase 2
• The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional StudyCompletedNCT05463276
• Mindfulness Yoga and Sexual FunctioningStatus unknownNCT05461534Not applicable
• Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
• Relationship Between Breast Cancer Subtypes and Immune CheckpointsCompletedNCT05460702
• Acceptance and Usability of an App Promoting Healthy Behaviours Amongst Young Women at Increased Risk of Breast CancerCompletedNCT05460650Not applicable
• A Digital Solution for Breast Cancer PatientsCompletedNCT05459454Not applicable
• Tucatinib+Trastuzumab+Eribulin in HER2+ MBCActive, not recruitingNCT05458674Phase 2
• Ethnic Predisposition, Risk Factors & Breast Cancer Presentation.CompletedNCT05458570
• Dedicated Breast CT for Diagnosis of Breast CancerTerminatedNCT05458427
• EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab DeruxtecanCompletedNCT05458401
• The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) TreatmentActive, not recruitingNCT05458284Phase 2
• Intraoperative Use of ClearEdge Device in Breast Conserving SurgeryStatus unknownNCT05456373Not applicable
• The Added Value of a Third Supervised Training Session to a Standard 12-week Rehabilitation Program After Breast Cancer: Pilot StudyCompletedNCT05455385Not applicable
• Efficacity of Deep Inspiration Breath Hold and Intensity-modulated Radiotherapy in Preventing PErfusion Defect for Left Sided Breast Cancer (EDIPE)Status unknownNCT05454553Not applicable
• Investigation of Urinary Biomarkers for the Detection of Breast CancerStatus unknownNCT05453591Not applicable
• Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer SurvivorsTerminatedNCT05452681Not applicable
• Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With SequelaeCompletedNCT05452499Not applicable
• Multidisciplinary Care Pathway With Electronic Patient Reported Outcomes (ePRO) Post-operative Follow-up of Breast Cancer Surgery Complications to Optimize Patient Quality of LifeCompletedNCT05449340Not applicable
• Pilot Study of Single-port Robot-assisted Nipple-sparing MastectomyStatus unknownNCT05448963Not applicable
• Transversus Thoracic Muscle Plane Combined With Pectoral Nerves Block for Breast Cancer SurgeryCompletedNCT05448638Not applicable
• The Effect of Walking Exercise Based on TOUS on Peripheral Neuropathy and Arthralgia-Myalgia in Women With Breast CancerCompletedNCT05448209Not applicable
• Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast CancerTerminatedNCT05447910
• Neoadjuvant Inetetamab and Pyrotinib and Nab-paclitaxel for HER2+Breast CancerCompletedNCT05444998Phase 2
• Investigating Barriers for Decision Making in a Danish Breast Cancer Screening ContextCompletedNCT05444725Not applicable
• Breaking Through the Brain Fog: An Online Research StudyCompletedNCT05444231Not applicable
• Optimizing Psychological Treatment for Pain After Breast CancerStatus unknownNCT05444101Not applicable
• Multi-center Study of Deep Learning AI in Breast MassStatus unknownNCT05443672
• Lymphaticovenous Anastomosis as Treatment for LymphedemaActive, not recruitingNCT05441943Not applicable
• CIPN in Early Stage Breast Cancer PatientsActive, not recruitingNCT05441722Not applicable
• Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI TechnologyStatus unknownNCT05441098
• This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.Status unknownNCT05439499Phase 3
• This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.Status unknownNCT05438810Phase 3
• A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast CancerStatus unknownNCT05438706Phase 2
• Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast CancerWithdrawnNCT05436808Early Phase 1
• A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast CancerActive, not recruitingNCT05433480Phase 3
• Topical Menthol Application in Chemotherapy-Related Peripheral Neuropathy in Patients With Breast CancerCompletedNCT05429814Not applicable
• Precise Therapy for Refractory HER2 Positive Advanced Breast CancerStatus unknownNCT05429684Phase 3
• Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038Status unknownNCT05429294Phase 2
• Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast CancerCompletedNCT05427617
• A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer PatientsActive, not recruitingNCT05426486Phase 2/3
• Evaluation of the Medidux™ Digital Health Application in Patients With HER2-positive Breast Cancer.TerminatedNCT05425550Not applicable
• The Role of Lipofilling After Oncoplastic Breast Surgeries : Evaluation of Outcomes and Patient SatisfactionStatus unknownNCT05424666Not applicable
• Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer SurvivorsCompletedNCT05417451Phase 2
• Clinical Study of Glycosylated Extracellular Vesicles for Early Diagnosis of Breast CancerStatus unknownNCT05417048
• Safety and Efficacy Assessment of Diagnostic Microprobe (inPROBE) in Women at High Risk of Breast Cancer (Part I Study)CompletedNCT05415943Not applicable
• Intervening on Women's Health for Rural Young Breast Cancer SurvivorsCompletedNCT05414812Not applicable
• Tonation Breathing Technique Method to Ease Aromatase Inhibitor-induced Joint and/or Muscle PainCompletedNCT05412953Not applicable
• 99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted TherapyCompletedNCT05412459
• 99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph NodesCompletedNCT05412446Phase 2
• Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.Status unknownNCT05411380Phase 2
• Moving Forward Together 4Active, not recruitingNCT05409664Not applicable
• Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer SurgeryCompletedNCT05408676Not applicable
• A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast CancerCompletedNCT05408260Not applicable
• of Androgen Receptor Expression in Breast Cancer With or Without BRCA MutationCompletedNCT05404334
• Evaluation of Contrast Enhanced Breast CT for Diagnosis and Staging of Breast CancerStatus unknownNCT05404087
• Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast CancerStatus unknownNCT05403333Phase 2
• Angiomammography and Neoadjuvant ChemotherapyCompletedNCT05402930Not applicable
• Study of Eribulin in Combination With Anti-PD-1 Antibody in Patients With Metastatic Triple-Negative Breast CancerStatus unknownNCT05402722Phase 2
• Real-time Tele-monitoring Versus Routine Monitoring of Breast Cancer Patients Receiving Adjuvant Systemic TherapyStatus unknownNCT05401942Not applicable
• Factors Affecting Rehabilitation Time for Postoperative Complications Among Breast Cancer PatientsCompletedNCT05401877

← Breast Neoplasms overview